Skin Grafts Market Size, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027
Report ID: GMI3156
Skin Grafts Market size is projected to experience significant growth from 2019 to 2025.
Rising prevalence of skin cancer, rising demand for skin graft and new product launch by market players will drive skin graft market. According to American Academy of Dermatology, more than 1 million Americans suffer annually from skin cancer and the prevalence is rising. Growing pervasiveness of skin disorders such as tissue necrosis and burns will stimulate demand for skin grafts in the coming years.
Increasing number of accidents and burns in recent years have surged the demand for skin grafts. This is fueled by rapid urbanization and increasing purchases of automobiles. Skin grafts assist in improving the appearance and function of the body where the graft is used. Other advantages associated with skin grafts such as reduced incision and greater recovery time will boost market growth.
Additionally, the market players are developing new skin grafts for several medical applications like tissue transplant. This is expected to further supplement growth of market in the future. Technological advancements in equipment like dermatomes and other surgical instruments are expected to encourage the skin graft market growth.
Risks associated with skin grafting such as internal bleeding, reduced skin sensation and uneven skin surface could impede skin graft market growth. Lack of necessary infrastructure and high costs associated with skin grafts could obstruct skin grafts market growth.
Recently, there have been significant advancements in autologous skin grafting. For instance, dermal-epidermal graft expansion techniques and novel autologous cell cultures have witnessed significant advancements in recent years. These advancements are expected to further the skin graft market growth.
One of the most commonly used type of skin graft based on thickness is split-thickness graft. By removing only epidermis and a part of dermis, it allows quick healing of source site. They cover large areas and rate of auto-rejection is also low, thereby increasing patient inclination towards split-thickness graft.
Increasing incidences of both melanoma and non-melanoma skin cancers will considerably fuel skin graft market growth in the coming years. As skin grafts are associated with minimal donor-site morbidity they are mostly preferred for reconstructive surgery. Further, recent advancements in skin grafting techniques will assist in early adoption of skin grafts by healthcare professionals.
Skin grafting surgeries are usually done in hospitals. Many hospitals also provide in-house physical therapy to its patients. Since hospitals provide all the necessary amenities for patients, the number of patients opting skin graft surgeries in hospitals is expected to grow in the future.
U.S. is expected to dominate the North America skin graft market in the forecast period. The factors that will drive the market growth are increasing incidences of skin infections, burn injuries, skin cancer patients and technical advancements in dermatomes. Greater expenditure on healthcare supplemented by faster uptake of new technology will bolster the U.S. skin graft market growth.
Some of the prominent players of skin graft market include Avita Medical, B. Braun Melsungen AG, De Soutter Medical Limited, Integra Lifesciences Corporation, MiMedx, Nouvag AG, Organogenesis, Inc., Surtex Instruments, Limited, Tissue Regenix and Zimmer Biomet. The competitors have focused on strategies such as product launch and expansion into new markets to strengthen market position.
Skin grafts market, by types, 2014-2025 (USD Million)
Skin grafts market, by graft thickness, 2014-2025 (USD Million)
- Composite graft
Skin grafts market, by application, 2014-2025 (USD Million)
- Skin cancer
- Extensive wound
Skin grafts market, by end-use, 2014-2025 (USD Million)
- Dermatology clinics
- Ambulatory surgical centers
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
- South Africa
- Saudi Arabia
- Avita Medical
- B. Braun Melsungen AG
- De Soutter Medical Limited
- Integra Lifesciences Corporation
- Nouvag AG
- Organogenesis, Inc.
- Surtex Instruments Limited
- Tissue Regenix
- Zimmer Biomet
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability
Benefits of Association
Data Coverage & Quality
GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.
Client Trust & Security
GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.
Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.